» Articles » PMID: 25914844

Association Between Pre-biopsy White Blood Cell Count and Prostate Biopsy - Related Sepsis

Overview
Specialty Urology
Date 2015 Apr 28
PMID 25914844
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Despite all preventive measures and improved biopsy techniques, serious, life-threatening complications of prostate biopsy, including sepsis, still exist. In the present study, in order to identify the risk factors that may be associated with sepsis development after prostate-biopsy, we aimed to analyze retrospectively the data of our patients who underwent transrectal ultrasound-guided prostate biopsy.

Material And Methods: We retrospectively reviewed the data of 889 patients who underwent prostate biopsy at our clinic. We compared pre-biopsy parameters (age, prostate volume, white blood cell (WBC) count, fasting blood glucose, free and total prostate specific antigen levels) between patients who developed sepsis and those who were sepsis-free following prostate biopsy.

Results: 28 patients (3.1%) developed sepsis. Among the risk factors evaluated, only pre-biopsy WBC count was found to be a significant risk factor for biopsy-related sepsis. A 5.1 fold increase was detected in the risk for sepsis development, when the cut-off value of WBC was accepted as 11.165/μL, OR: 5.1 (95% CI: 2.3-11.5). The post-biopsy sepsis development rate in patients with pre-biopsy WBC count greater and less than 11.165/μL was 13.7% (n = 10) and 3% (n = 18) respectively.

Conclusions: Patients with a pre-biopsy WBC count greater than 11.165/μL should be informed of the increased risk of developing post-biopsy sepsis.

Citing Articles

Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis.

Lahdensuo K, Rannikko A, Anttila V, Erickson A, Patari-Sampo A, Rautio M Prostate Cancer Prostatic Dis. 2016; 19(4):417-422.

PMID: 27526964 DOI: 10.1038/pcan.2016.36.

References
1.
Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M . Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol. 2001; 166(3):856-60. View

2.
Sagi H, Dziadosz D, Mir H, Virani N, Olson C . Obesity, leukocytosis, embolization, and injury severity increase the risk for deep postoperative wound infection after pelvic and acetabular surgery. J Orthop Trauma. 2012; 27(1):6-10. DOI: 10.1097/BOT.0b013e31825cf382. View

3.
Sheikh M, Hussein A, Kehinde E, Al-Saeed O, Rad A, Ali Y . Patients' tolerance and early complications of transrectal sonographically guided prostate biopsy: prospective study of 300 patients. J Clin Ultrasound. 2005; 33(9):452-6. DOI: 10.1002/jcu.20168. View

4.
Puig J, Darnell A, Bermudez P, Malet A, Serrate G, Bare M . Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?. Eur Radiol. 2006; 16(4):939-43. DOI: 10.1007/s00330-005-0076-2. View

5.
Raja J, Ramachandran N, Munneke G, Patel U . Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol. 2006; 61(2):142-53. DOI: 10.1016/j.crad.2005.10.002. View